Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 29, 2018
CorMedix, Inc. Reports Progress on LOCK- IT 100 Data Review and Appoints Paul Chew as Consultant Advisor CMO
BERKELEY HEIGHTS, NJ / ACCESSWIRE / May 29, 2018 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products ...
May 29, 2018
STRATA Skin Sciences Announces Closing of a $17 Million Equity Financing and the Formal Appointment of New Management to Accelerate Growth and Enrich its XTRAC® Business Strategy
HORSHAM, Pa., May 29, 2018 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, ...
May 29, 2018
Aileron Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference
CAMBRIDGE, Mass., May 29, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (ALRN), the leader in the field of stapled peptide therapeutics for cancers and other diseases, ...
May 29, 2018
Brainsway Reports Record Financial Results for First Quarter of 2018 and Provides Corporate Update
HACKENSACK, N.J., May 29, 2018 (GLOBE NEWSWIRE) -- Brainsway Ltd. (BRIN.TA), a leader in the advanced non-invasive treatment of brain disorders, today announced the Company’s ...
May 29, 2018
BioTime Announces $1.9 Million Grant for Continued Development of OpRegen® for Dry-AMD
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, has been awarded a new grant for 2018 of up ...
May 29, 2018
Aimmune Therapeutics Announces Data on Terminology Used with Oral Immunotherapy Were Presented at EAACI 2018
BRISBANE, Calif. & MUNICH, Germany--(BUSINESS WIRE)--Aimmune Therapeutics, Inc. (AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies, today announced that data on terminology ...
May 29, 2018
PolarityTE to host Key Opinion Leader Summit
SALT LAKE CITY, May 29, 2018 (GLOBE NEWSWIRE) -- PolarityTE™, Inc. (COOL) today announced it will host a breakfast event in New York City with ...
May 29, 2018
RedHill Biopharma Announces New U.S. Patent for its Experimental Ebola Therapy
TEL-AVIV, Israel and RALEIGH, N.C., May 29, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical ...
May 29, 2018
Albireo to Present at Jefferies 2018 Global Healthcare Conference
BOSTON, May 29, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced ...
May 29, 2018
UroGen Pharma to Present at the Jefferies 2018 Global Healthcare Conference
RA’ANANA, Israel and NEW YORK, May 29, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs ...
May 29, 2018
Opiant Pharmaceuticals to Participate in The American Society of Clinical Psychopharmacology 2018 Annual Meeting
SANTA MONICA, Calif., May 29, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, today announced ...
May 29, 2018
FDA Clears Development Pathway for NexoBrid® for Sulfur Mustard Injuries
YAVNE, Israel, May 29, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn ...
May 29, 2018
Spring Bank to Present at Jefferies 2018 Global Healthcare Conference
HOPKINTON, Mass., May 29, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral ...
May 29, 2018
Arcturus Therapeutics Appoints Four New Directors and Reaches Settlement Agreement with Founder Joseph E. Payne
SAN DIEGO, May 29, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (ARCT) (“Arcturus” or the “Company), a leading RNA medicines company, today announced that, as ...
May 24, 2018
Prothena Announces Reorganization to Focus Resources on Advancing Neuroscience Pipeline
DUBLIN, Ireland, May 24, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (PRTA), a clinical-stage biotechnology company focused on the discovery and development of novel therapies ...
May 24, 2018
Eiger BioPharmaceuticals Prices Previously Announced Public Offering of Common Stock
PALO ALTO, Calif., May 24, 2018 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), a clinical-stage biopharmaceutical company focused on bringing to market novel product candidates for ...
May 24, 2018
BioTime Further Expands OpRegen® Clinical Trial in Dry-AMD With the Opening of Two Additional U.S. Sites
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced the expansion of its ongoing Phase I/IIa clinical ...
May 24, 2018
VBL Therapeutics to Present at Upcoming Conferences in June
TEL AVIV, Israel, May 24, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class ...
May 24, 2018
U.S. FDA Grants Fast Track Designation for Krystal Biotech’s KB103 for the Treatment of Dystrophic Epidermolysis Bullosa
PITTSBURGH, May 24, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech Inc., (“Krystal”) (KRYS), a gene therapy company developing topical and intradermal "off-the-shelf" treatments for rare dermatological ...
May 24, 2018
Achaogen Announces Multiple Plazomicin Presentations at ASM Microbe 2018 Annual Meeting
SOUTH SAN FRANCISCO, Calif., May 24, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative ...
Page 59 of 138